Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Depreciation & Amortization - Total: 2021-2024

Historic Depreciation & Amortization - Total for MDxHealth (MDXH) over the last 4 years, with Dec 2024 value amounting to $1.3 million.

  • MDxHealth's Depreciation & Amortization - Total rose 16.57% to $957,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 1045.27%. This contributed to the annual value of $1.3 million for FY2024, which is 51.24% up from last year.
  • As of FY2024, MDxHealth's Depreciation & Amortization - Total stood at $1.3 million, which was up 51.24% from $888,000 recorded in FY2023.
  • In the past 5 years, MDxHealth's Depreciation & Amortization - Total registered a high of $1.4 million during FY2021, and its lowest value of $750,000 during FY2022.
  • Over the past 3 years, MDxHealth's median Depreciation & Amortization - Total value was $888,000 (recorded in 2023), while the average stood at $993,667.
  • As far as peak fluctuations go, MDxHealth's Depreciation & Amortization - Total plummeted by 47.41% in 2022, and later skyrocketed by 51.24% in 2024.
  • Over the past 4 years, MDxHealth's Depreciation & Amortization - Total (MRY) stood at $1.4 million in 2021, then plummeted by 47.41% to $750,000 in 2022, then rose by 18.40% to $888,000 in 2023, then skyrocketed by 51.24% to $1.3 million in 2024.
  • Its Depreciation & Amortization - Total was $1.3 million in FY2024, compared to $888,000 in FY2023 and $750,000 in FY2022.